Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000570326 | SCV000674727 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000866936 | SCV001008106 | likely benign | Retinoblastoma | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001726251 | SCV001961410 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | RB1: BP4, BP7 |
Sema4, |
RCV000570326 | SCV002530818 | likely benign | Hereditary cancer-predisposing syndrome | 2021-09-18 | criteria provided, single submitter | curation |